Events & Presentations

PAST EVENTS

Date	Title
09/08/2021	Citi 16th Annual BioPharma Virtual Conference
07/14/2021	Ladenburg Thalmann Healthcare Conference
06/03/2021	Jefferies Virtual Healthcare Conference
05/05/2021	Zymeworks' Annual General Meeting Listen to webcast
04/20/2021	Bloom Burton Healthcare Investor Conference
04/10/2021	American Association for Cancer Research (AACR) Annual Meeting Supporting Materials Title: Super-resolution imaging studies of zanidatamab: providing insights into its bispecific mode of action 4.3 MB Title: The bispecific antibody zanidatamab’s (ZW25’s) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers 4.3 MB Title: ProTECT™, a novel antibody platform for integrating tumor-specific immune modulation and enhancing the therapeutic window of targeted multispecific biologics 9.3 MB Title: Increasing the therapeutic index of IL-12 by engineering for tumor-specific protease activation 2.7 MB Title: Understanding the geometry and valency of bispecific antibodies in the optimization of tumor-dependent activation of 4-1BB 5.2 MB
03/11/2021	Barclays Global Healthcare Conference
01/27/2021	ZW49 Clinical Update Conference Call Listen to webcast
01/15/2021	Zanidatamab ASCO GI Conference Call Audio Supporting Materials Presentation 15.6 MB
01/15/2021	American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Supporting Materials Title: A Phase 2b, Open-label, Single-arm Study of Zanidatamab (ZW25) Monotherapy in Patients with Advanced or Metastatic HER2-amplified Biliary Tract Cancer (BTC): HERIZON-BTC-01 Study 410.1 KB Title: Zanidatamab (ZW25) in HER2-positive Biliary Tract Cancer (BTC): Results From a Phase 1 Study 390.9 KB Title: Zanidatamab (ZW25) in HER2-expressing Gastroesophageal Adenocarcinoma (GEA): Results from a Phase 1 Study 1.8 MB

UPCOMING EVENTS

PAST EVENTS